Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Botulinum Neurotoxin Type A

Brand: Xeomin®
NICE TA: 605
Indication: For treating chronic sialorrhoea (NICE TA605)
Disease category: Central nervous system
Commissioning responsibility: CCG
PbR excluded: No


1.1 Xeomin (botulinum neurotoxin type A) is recommended, within its marketing authorisation, as an option for treating chronic sialorrhoea caused by neurological conditions in adults. It is recommended only if the company provides it according to the commercial arrangement.


LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

NICE TA605 - Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG